Software & Analysis
Most Accessed Equities:
Quotes last updated: Sep-15 13:30
Recent News Mentions
Ultragenyx Pharmaceutical Inc. (RARE) Lifted to “Hold” at Zacks Investment ...
Equities Analysts Issue Forecasts for Ultragenyx Pharmaceutical Inc.'s Q1 2018 ...
Investor Watch: Target Price Focus on Shares of Ultragenyx Pharmaceutical Inc ...
Ultragenyx Pharmaceutical Inc. Expected to Post Q1 2018 Earnings of ($1.75 ...
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Upgraded to “Hold” by Zacks ...
Ultragenyx's rhGUS Gets FDA Nod for Rare Genetic Disease
Ultragenyx Pharmaceutical Inc. (RARE) Rating Reiterated by Cowen and Company
Ultragenyx Pharmaceutical (RARE)
Canaccord Genuity Lowers Ultragenyx Pharmaceutical Inc. (RARE) Price Target to ...
Ultragenyx Announces Completion of Patient Dosing in First Cohort of Phase 1/2 ...
This equity's price and volume patterns don't yield results our systems can recommend trading.
Copyright Thinking Profit. All Rights Reserved. Please read our
Processed in 0.04 seconds.